ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling

Background Cardiac hypertrophy has been recognized as an important independent risk factor for the development of heart failure and increases the risk of cardiac morbidity and mortality. A disintegrin and metalloprotease 23 (ADAM23), a member of ADAM family, is involved in cancer and neuronal differ...

Full description

Bibliographic Details

Published in:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Main Authors:	Mei Xiang, Hongbo Luo, Jia Wu, Lingyun Ren, Xiangchao Ding, Chuangyan Wu, Jiuling Chen, Shanshan Chen, Hao Zhang, Lu Yu, Yanqiang Zou, Heng Xu, Ping Ye, Manhua Chen, Jiahong Xia
Format:	Article
Language:	English
Published:	Wiley 2018-09-01
Subjects:	a disintegrin and metalloprotease23 Akt cardiac hypertrophy focal adhesion kinase
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.118.008604